Research output per year
Research output per year
Personal profile
Biography
I am a postdoctoral researcher and a 2020 Forrest Fellow in the Brain Tumour Research Program, at the Telethon Kids Institute and the University of Western Australia. My current research includes medulloblastoma biology, drug discovery, radiotherapy and MR imaging.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Oncology, DPhil, Imaging angiogenesis in brain metastasis, University of Oxford
Award Date: 15 Jul 2019
Neuroscience, MSc
Award Date: 26 Oct 2015
External positions
Honorary Research Associate, Telethon Kids Institute
Research expertise keywords
- Brain tumours
- Cancer biology
- Mouse models
- Radiation oncology
- Neurobiology
- Magnetic resonance imaging (MRI)
Fingerprint
Dive into the research topics where Jessica Buck is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cancer therapies inducing DNA damage
Buck, J., Bowden, N. & Endersby, R., 1 Jan 2022, Epigenetics and DNA Damage. Galvonas Jasiulionis, M. (ed.). Academic Press, Vol. 33. p. 205-225 21 p. (Translational Epigenetics Series).Research output: Chapter in Book/Conference paper › Chapter › peer-review
-
ENHANCING ANTI-CD47 MAB EFFICACY WITH RADIOTHERAPY FOR GROUP 3 PAEDIATRIC MEDULLOBLASTOMA IN PRECLINICAL MODELS
Abbas, Z., Buck, J., Ancliffe, M., Arias, C. A., Howlett, M., Hii, H., Johns, T., Mitra, S., Gottardo, N. & Endersby, R., Jun 2022, In: Neuro-Oncology. 24, p. 172-172 1 p.Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
-
ENHANCING THE ACTIVITY OF ANTI-CD47 ANTIBODY THERAPY WITH RADIOTHERAPY IN PRECLINICAL MODELS OF MEDULLOBLASTOMA
Abbas, Z., Howlett, M., Buck, J., Hii, H., Kuchibhotla, M., Ancliffe, M., Whitehouse, J., Johns, T., Ebert, M., Gottardo, N. & Endersby, R., 5 Sept 2022, In: Neuro-Oncology. 24, 1 p.Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
-
Exploiting DNA damage response inhibitors to enhance radiation efficacy in medulloblastoma models
Dholaria, H., Buck, J., Hii, H., Carline, B., Bryne, J., Kuchibhotla, M., Lawler, J., Porter, G., Whitehouse, J., Howlett, M., Gottardo, N. & Endersby, R., Jun 2022, In: Neuro-Oncology. 24, p. 173-173 1 p.Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
-
Fractionated radiotherapy is required to accurately mimic neurostructural late effects in preclinical models
Whitehouse, J., Howlett, M., Buck, J., Somers, K., Lawler, J., Hii, H., Carline, B., Kuchibhotla, M., Sewoo, B., Rosenow, T., Feindel, K., Ebert, M., Mehnert, A., Gottardo, N. & Endersby, R., Jun 2022, In: Neuro-Oncology. 24, p. 177-177 1 p.Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
Projects
- 1 Active